https://www.mdpi.com/1422-0067/22/20/10984/htm
G-Quadruplex Targeting in the Fight against Viruses: An Update
Department of Molecular Medicine, University of Padua, 35121 Padua, Italy
*
Author to whom correspondence should be addressed. 
†
These authors contributed equally to this work.
Academic Editor: Alessandro Di Minno
Int. J. Mol. Sci. 2021, 22(20), 10984; https://doi.org/10.3390/ijms222010984
Received: 20 September 2021
/
Revised: 7 October 2021
/
Accepted: 8 October 2021
/
Published: 12 October 2021
Abstract
G-quadruplexes (G4s) are noncanonical nucleic acid structures involved 
in the regulation of key cellular processes, such as transcription and 
replication. Since their discovery, G4s have been mainly investigated 
for their role in cancer and as targets in anticancer therapy. More 
recently, exploration of the presence and role of G4s in viral genomes 
has led to the discovery of G4-regulated key viral pathways. In this 
context, employment of selective G4 ligands has helped to understand the
 complexity of G4-mediated mechanisms in the viral life cycle, and 
highlighted the possibility to target viral G4s as an emerging antiviral
 approach. Research in this field is growing at a fast pace, providing 
increasing evidence of the antiviral activity of old and new G4 ligands.
 This review aims to provide a punctual update on the literature on G4 
ligands exploited in virology. Different classes of G4 binders are 
described, with emphasis on possible antiviral applications in emerging 
diseases, such as the current COVID-19 pandemic. Strengths and 
weaknesses of G4 targeting in viruses are discussed.
View Full-Text
Keywords: 
 G-quadruplexes; virus; targeting; G-quadruplex ligands; antiviral therapy
▼
Show Figures



Inga kommentarer:
Skicka en kommentar